HLA-D antigens in progressive systemic sclerosis (scleroderma).

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Immunological Communications

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/08820138109051959PMID 6210624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HLA and scleroderma.

  2008cited by this paper
• HLA and scleroderma.

  1979cited by this paper
• Histocompatibility antigens in progressive systemic sclerosis (scleroderma).

  1977cited by this paper
• Cellular infiltrates in scleroderma skin.

  1977cited by this paper
• Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).

  1976cited by this paper
• Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families

  1975cited by this paper
• The mixed-leukocyte reaction in man: effect of pools of stimulating cells selected on the basis of crossreacting HL-A specificities.

  1974cited by this paper
• Impaired mixed leucocyte reaction in some different diseases, notably multiple sclerosis and various arthritides.

  1971cited by this paper
• Serologic alterations in scleroderma and sclerodermatomyositis.

  1971cited by this paper
• Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

  1968cited by this paper
• MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.

  1964cited by this paper

• Non-atherosclerotic and non-vasculitic diseases

  2002cites this paper
• Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.

  1995cites this paper
• Position 26 of the first domain of the HLA-DQB1 allele in post-silicone implant scleroderma.

  1995cites this paper
• Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.

  1994cites this paper
• The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

  1993cites this paper
• HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.

  1992cites this paper
• Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

  1992cites this paper
• Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

  1992cites this paper
• Genetic factors in scleroderma.

  1990cites this paper
• Immunogenetic associations of scleroderma-related antinuclear antibodies.

  1990cites this paper
• Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the literature.

  1989cites this paper
• Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.

  1987cites this paper
• Scleroderma as a Fibrotic Disorder

  1985cites this paper
• Immunology of Rheumatic Diseases

  1985cites this paper
• Connective Tissue Diseases

  1985cites this paper
• Scleroderma: possible significance of silent alleles at the C4B locus.

  1984cites this paper
• HLA-DR antigens in progressive systemic sclerosis (scleroderma).

  1983cites this paper
• Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma)

  1982cites this paper